Fujimoto, Kiyohide
3 papers on CoChatORCID 0000-0003-1507-2464
Most cited papers
- Verified
Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial
Powles, T., Csőszi, T., Özgüroğlu, M., Matsubara, N., Géczi, L., Cheng, S. Y.-S., Fradet, Y., Oudard, S., Vulsteke, C., Morales Barrera, R., et al. (2021) · The Lancet Oncology
Bladder and Urothelial Cancer TreatmentsCancer Immunotherapy and Biomarkers
Cited by 643
- Verified
siRNA-mediated knockdown of the heme synthesis and degradation pathways: Modulation of treatment effect of 5-aminolevulinic acid-based photodynamic therapy in urothelial cancer cell lines
Miyake, M., Ishii, M., Kawashima, K., Kodama, T., Sugano, K., Fujimoto, K., & Hirao, Y. (2009) · Photochemistry and Photobiology
Photodynamic Therapy Research StudiesHeme Oxygenase-1 and Carbon Monoxide
Cited by 79
- Verified
Function of JunB in transient amplifying cell senescence and progression of human prostate cancer.
Konishi, N., Shimada, K., Nakamura, M., Ishida, E., Ota, I., Tanaka, N., & Fujimoto, K. (2008) · Clinical Cancer Research
Telomeres, Telomerase, and SenescenceProstate Cancer Treatment and Research
Cited by 46
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free